Bortezomib

Generic name: Pronounced as (bor tez' oh mib)
Brand names
  • Velcade®
Click on drug name to hear pronunciation

Medical Content Reviewed By HelloPharmacist Staff

Last Revised - 11/15/2019

Bortezomib is used to treat people with multiple myeloma (a type of cancer of the bone marrow). Bortezomib is also used to treat people with mantle cell lymphoma (a fast-growing cancer that begins in the cells of the immune system). Bortezomib is in a class of medications called antineoplastic agents. It works by killing cancer cells.

Bortezomib comes as a solution (liquid) to inject into a vein or subcutaneously (under the skin). Bortezomib is given by a doctor or nurse in a medical office or clinic. Your dosing schedule will depend on the condition that you have, the other medications you are using, and how well your body responds to treatment.

Be sure to tell your doctor how you are feeling during your treatment. Your doctor may stop your treatment for a while or decrease your dose of bortezomib if you experience side effects of the medication.

Ask your pharmacist or doctor for a copy of the manufacturer's information for the patient.

This medication may be prescribed for other uses; ask your doctor or pharmacist for more information.

Before using bortezomib,

  • tell your doctor and healthcare provider if you are allergic to bortezomib, mannitol, any other medications, boron, or any of the ingredients in bortezomib. Ask your healthcare provider for a list of the ingredients.

  • tell your doctor and pharmacist what other prescription and nonprescription medications, vitamins, or nutritional supplements you are taking or plan to take. Be sure to mention any of the following: clarithromycin (Biaxin, in PrevPac); certain antifungals such as itraconazole (Sporanox) or ketoconazole (Nizoral); idelalisib (Zydelig); medications to treat diabetes or high blood pressure; certain medications to treat human immunodeficiency virus (HIV) or acquired immunodeficiency syndrome (AIDS) such as indinavir (Crixivan), nelfinavir (Viracept), ritonavir (Norvir), or saquinavir (Invirase); certain medications to treat seizures such as carbamazepine (Carbatrol, Tegretol), phenobarbital (Luminal, Solfoton), or phenytoin (Dilantin, Phenytek); nefazodone; ribociclib (Kisqali, Kisqali, in Femera); rifabutin (Mycobutin); or rifampin (Rifadin, Rifamate, Rimactane, others). Your doctor may need to change the doses of your medications or monitor you carefully for side effects. Many other medications may also interact with bortezomib, so be sure to tell your doctor about all the medications you are taking, even those that do not appear on this list.

  • tell your doctor what herbal products you are taking, especially St. John's wort.

  • tell your doctor if you or anyone in your family has or has ever had heart disease and if you have or have ever had a herpes infection (cold sores, shingles, or genital sores); diabetes; fainting; high cholesterol (fats in the blood); low or high blood pressure; peripheral neuropathy (numbness, pain, tingling, or burning feeling in the feet or hands) or weakness or loss of feeling or reflexes in a part of your body;or kidney or liver disease. Also tell your doctor if you smoke or drink large amounts of alcohol.

  • tell your doctor if you are pregnant or plan to become pregnant. Bortezomib may harm the fetus. Use birth control to prevent pregnancy during your treatment with bortezomib and for at least 7 months after your final dose. If you are a male with a female partner who could become pregnant, be sure to use birth control during your treatment with bortezomib and for at least 4 months after your final dose. Ask your doctor if you have questions about types of birth control that will work for you. If you or your partner become pregnant while using bortezomib or for 7 months after your final dose, call your doctor immediately.

  • do not breastfeed during your treatment with bortezomib and for 2 months after your final dose.

  • if you are having surgery, including dental surgery, tell the doctor or dentist that you are using bortezomib.

  • you should know that bortezomib may make you drowsy, dizzy, or lightheaded, or cause fainting or blurred vision. Do not drive a car or operate machinery or dangerous tools until you know how this medication affects you.

  • you should know that bortezomib may cause dizziness, lightheadedness, and fainting when you get up too quickly from a lying position. This is more common in people who have fainted in the past, people who are dehydrated, and people who are taking medications that lower blood pressure. To avoid this problem, get out of bed slowly, resting your feet on the floor for a few minutes before standing up.

Talk to your doctor about eating grapefruit and drinking grapefruit juice while using this medication.

Drink plenty of fluids every day during your treatment with bortezomib, especially if you vomit or have diarrhea.

If you miss an appointment to receive a dose of bortezomib, call your doctor right away.

  • Bortezomib may cause side effects. Tell your doctor if any of these symptoms, or those in the SPECIAL PRECAUTIONS section, are severe or do not go away:

    • general weakness

    • tiredness

    • nausea

    • vomiting

    • diarrhea

    • constipation

    • loss of appetite

    • stomach pain

    • headache

    • pain, redness, bruising, bleeding, or hardness at injection site

    • difficulty falling asleep or staying asleep

  • Some side effects can be serious. If you experience any of these symptoms, call your doctor immediately:

    • weakness in the arms or legs, changes in the sense of touch, or pain, burning, numbness, or tingling in the hands, arms, legs, or feet

    • sudden shooting or stabbing pain, constant aching or burning pain, or muscle weakness

    • shortness of breath, fast heartbeat, headache, dizziness, pale skin, confusion, or tiredness

    • swelling of the feet, ankles, or lower legs

    • hives, rash, itching

    • hoarseness, difficulty swallowing or breathing, or swelling of the face, throat, tongue, lips, eyes, or hands

    • fever, sore throat, chills, cough or other signs of infection

    • unusual bruising or bleeding

    • black and tarry stools, red blood in stools, bloody vomit, or vomiting material that looks like coffee grounds

    • slurred speech or inability to speak or understand speech, confusion, paralysis (loss of ability to move a part of the body), vision changes, or loss of vision, balance, coordination, memory or consciousness

    • fainting, blurred vision, dizziness, nausea, or muscle cramps

    • chest pressure or pain, fast heartbeat, swelling of the ankles or feet, or shortness of breath

    • cough, shortness of breath, wheezing, or difficulty breathing

    • headache, confusion, seizures, tiredness, or vision loss or changes

    • pinpoint-sized purple dots under the skin, fever, tiredness, dizziness, shortness of breath, bruising, confusion, sleepiness, seizures, decreased urination, blood in the urine, or swelling in legs

    • fever, headache, chills, nausea, pain, itching or tingling followed by a rash in the same area with skin blisters that are itchy or painful

    • nausea, extreme tiredness, unusual bleeding or bruising, lack of energy, loss of appetite, pain in the upper right part of the stomach, yellowing of the skin or eyes, or flu-like symptoms

  • Bortezomib may cause other side effects. Call your doctor if you have any unusual problems while receiving this medication.

Bortezomib will be stored in the medical office or clinic.

In case of overdose, call the poison control helpline at 1-800-222-1222. Information is also available online at https://www.poisonhelp.org/help. If the victim has collapsed, had a seizure, has trouble breathing, or can't be awakened, immediately call emergency services at 911.

Symptoms of overdose may include the following:

  • fainting

  • dizziness

  • blurred vision

  • unusual bruising or bleeding

Keep all appointments with your doctor and the laboratory. Your doctor will order certain lab tests to check your body's response to bortezomib.

It is important for you to keep a written list of all of the prescription and nonprescription (over-the-counter) medicines you are taking, as well as any products such as vitamins, minerals, or other dietary supplements. You should bring this list with you each time you visit a doctor or if you are admitted to a hospital. It is also important information to carry with you in case of emergencies.

Drug Interaction
Moxifloxacin Moxifloxacin The metabolism of Bortezomib can be decreased when combined with Moxifloxacin.
Montelukast Montelukast The metabolism of Montelukast can be decreased when combined with Bortezomib.
Insulin Glargine (rDNA origin) Injection Insulin Glargine (rDNA origin) Injection The metabolism of Bortezomib can be increased when combined with Insulin glargine.
Leflunomide Leflunomide The risk or severity of adverse effects can be increased when Leflunomide is combined with Bortezomib.
Delavirdine Delavirdine The metabolism of Bortezomib can be decreased when combined with Delavirdine.
Nevirapine Nevirapine The metabolism of Nevirapine can be decreased when combined with Bortezomib.
Dolasetron Dolasetron The risk or severity of QTc prolongation can be increased when Bortezomib is combined with Dolasetron.
Aminophylline Aminophylline The metabolism of Aminophylline can be decreased when combined with Bortezomib.
Anagrelide Anagrelide The risk or severity of QTc prolongation can be increased when Bortezomib is combined with Anagrelide.
Candesartan Candesartan The metabolism of Bortezomib can be decreased when combined with Candesartan.
Cilostazol Cilostazol The serum concentration of Cilostazol can be increased when it is combined with Bortezomib.
Clopidogrel Clopidogrel The metabolism of Clopidogrel can be decreased when combined with Bortezomib.
Erythromycin and Sulfisoxazole Erythromycin and Sulfisoxazole The metabolism of Erythromycin can be decreased when combined with Bortezomib.
Estrogen and Progestin (Oral Contraceptives) Estrogen and Progestin (Oral Contraceptives) The metabolism of Bortezomib can be decreased when combined with Conjugated estrogens.
Fenofibrate Fenofibrate The metabolism of Bortezomib can be decreased when combined with Fenofibrate.
Methylergonovine Methylergonovine The metabolism of Bortezomib can be decreased when combined with Methylergometrine.
Mycophenolate Mycophenolate The risk or severity of adverse effects can be increased when Bortezomib is combined with Mycophenolic acid.
Paregoric Paregoric The serum concentration of Bortezomib can be increased when it is combined with Morphine.
Penbutolol Penbutolol The risk or severity of QTc prolongation can be increased when Bortezomib is combined with Acebutolol.
Prednisone Prednisone The risk or severity of adverse effects can be increased when Bortezomib is combined with Prednisone.
Ranitidine Ranitidine The metabolism of Ranitidine can be decreased when combined with Bortezomib.
Reserpine Reserpine The serum concentration of Bortezomib can be increased when it is combined with Reserpine.
Tacrolimus Tacrolimus Tacrolimus may increase the immunosuppressive activities of Bortezomib.
Tizanidine Tizanidine The metabolism of Tizanidine can be decreased when combined with Bortezomib.
Triamcinolone Triamcinolone The metabolism of Triamcinolone can be increased when combined with Bortezomib.
Zolmitriptan Zolmitriptan The metabolism of Zolmitriptan can be decreased when combined with Bortezomib.
Doxycycline Injection Doxycycline Injection The metabolism of Bortezomib can be decreased when combined with Doxycycline.
Famotidine Injection Famotidine Injection The risk or severity of QTc prolongation can be increased when Bortezomib is combined with Famotidine.
Fluconazole Injection Fluconazole Injection The metabolism of Bortezomib can be decreased when combined with Fluconazole.
Foscarnet Injection Foscarnet Injection The risk or severity of QTc prolongation can be increased when Bortezomib is combined with Foscarnet.
Hydromorphone Injection Hydromorphone Injection The metabolism of Hydromorphone can be decreased when combined with Bortezomib.
Interferon Beta-1b Injection Interferon Beta-1b Injection The risk or severity of adverse effects can be increased when Interferon beta-1b is combined with Bortezomib.
Interferon Gamma-1b Injection Interferon Gamma-1b Injection The risk or severity of adverse effects can be increased when Interferon gamma-1b is combined with Bortezomib.
Levofloxacin Injection Levofloxacin Injection The risk or severity of QTc prolongation can be increased when Bortezomib is combined with Levofloxacin.
Meperidine Injection Meperidine Injection The metabolism of Bortezomib can be increased when combined with Meperidine.
Methylprednisolone Injection Methylprednisolone Injection The metabolism of Methylprednisolone can be increased when combined with Bortezomib.
Metoclopramide Injection Metoclopramide Injection The metabolism of Bortezomib can be decreased when combined with Metoclopramide.
Metronidazole Injection Metronidazole Injection The metabolism of Bortezomib can be decreased when combined with Metronidazole.
Morphine Injection Morphine Injection The serum concentration of Bortezomib can be increased when it is combined with Morphine.
Zidovudine Injection Zidovudine Injection The risk or severity of adverse effects can be increased when Bortezomib is combined with Zidovudine.
Altretamine Altretamine The metabolism of Bortezomib can be decreased when combined with Amphetamine.
Cyclosporine Cyclosporine Bortezomib may increase the immunosuppressive activities of Cyclosporine.
Ondansetron Ondansetron The risk or severity of QTc prolongation can be increased when Bortezomib is combined with Ondansetron.
Enoxaparin Injection Enoxaparin Injection The risk or severity of bleeding can be increased when Enoxaparin is combined with Bortezomib.
Granisetron Granisetron The risk or severity of QTc prolongation can be increased when Bortezomib is combined with Granisetron.
Torsemide Torsemide The metabolism of Torasemide can be decreased when combined with Bortezomib.
Olanzapine Olanzapine The metabolism of Olanzapine can be decreased when combined with Bortezomib.
Alosetron Alosetron The metabolism of Alosetron can be decreased when combined with Bortezomib.
Dofetilide Dofetilide The risk or severity of QTc prolongation can be increased when Bortezomib is combined with Dofetilide.
Entacapone Entacapone The metabolism of Bortezomib can be decreased when combined with Entacapone.
Hydroxychloroquine Hydroxychloroquine The risk or severity of adverse effects can be increased when Bortezomib is combined with Hydroxychloroquine.
Meloxicam Meloxicam The metabolism of Meloxicam can be decreased when combined with Bortezomib.
Orlistat Orlistat The metabolism of Bortezomib can be increased when combined with Orlistat.
Oxcarbazepine Oxcarbazepine The metabolism of Bortezomib can be increased when combined with Oxcarbazepine.
Pantoprazole Pantoprazole The metabolism of Pantoprazole can be decreased when combined with Bortezomib.
Temozolomide Temozolomide The risk or severity of adverse effects can be increased when Bortezomib is combined with Temozolomide.
Anakinra Anakinra The metabolism of Bortezomib can be increased when combined with Anakinra.
Desloratadine Desloratadine The risk or severity of QTc prolongation can be increased when Bortezomib is combined with Desloratadine.
Linezolid Linezolid The risk or severity of adverse effects can be increased when Bortezomib is combined with Linezolid.
Pentosan Polysulfate Pentosan Polysulfate The risk or severity of bleeding can be increased when Pentosan polysulfate is combined with Bortezomib.
Trimipramine Trimipramine The metabolism of Trimipramine can be decreased when combined with Bortezomib.
Etanercept Injection Etanercept Injection The metabolism of Bortezomib can be increased when combined with Etanercept.
Modafinil Modafinil The metabolism of Bortezomib can be increased when combined with Armodafinil.
Tenofovir Tenofovir The metabolism of Bortezomib can be decreased when combined with Tenofovir.
Sirolimus Sirolimus The risk or severity of adverse effects can be increased when Bortezomib is combined with Sirolimus.
Epinephrine Injection Epinephrine Injection The metabolism of Bortezomib can be decreased when combined with Epinephrine.
Epirubicin Epirubicin The risk or severity of adverse effects can be increased when Epirubicin is combined with Bortezomib.
Escitalopram Escitalopram The serum concentration of Escitalopram can be increased when it is combined with Bortezomib.
Zonisamide Zonisamide The serum concentration of Zonisamide can be increased when it is combined with Bortezomib.
Adalimumab Injection Adalimumab Injection The metabolism of Bortezomib can be increased when combined with Adalimumab.
Aripiprazole Aripiprazole The risk or severity of QTc prolongation can be increased when Bortezomib is combined with Aripiprazole.
Atomoxetine Atomoxetine The risk or severity of QTc prolongation can be increased when Bortezomib is combined with Atomoxetine.
Glatiramer Injection Glatiramer Injection The risk or severity of adverse effects can be increased when Bortezomib is combined with Glatiramer.
Atazanavir Atazanavir The metabolism of Atazanavir can be decreased when combined with Bortezomib.
Almotriptan Almotriptan The metabolism of Almotriptan can be decreased when combined with Bortezomib.
Eletriptan Eletriptan The metabolism of Eletriptan can be decreased when combined with Bortezomib.
Mefloquine Mefloquine The metabolism of Mefloquine can be decreased when combined with Bortezomib.
Rosuvastatin Rosuvastatin The metabolism of Rosuvastatin can be decreased when combined with Bortezomib.
Vardenafil Vardenafil The serum concentration of Bortezomib can be increased when it is combined with Vardenafil.
Alfuzosin Alfuzosin The risk or severity of QTc prolongation can be increased when Bortezomib is combined with Alfuzosin.
Aprepitant Aprepitant The metabolism of Bortezomib can be decreased when combined with Aprepitant.
Interferon Beta-1a Subcutaneous Injection Interferon Beta-1a Subcutaneous Injection The metabolism of Bortezomib can be decreased when combined with Interferon beta-1a.
Tegaserod Tegaserod The metabolism of Bortezomib can be decreased when combined with Tegaserod.
Frovatriptan Frovatriptan The metabolism of Frovatriptan can be decreased when combined with Bortezomib.
Gemifloxacin Gemifloxacin The risk or severity of QTc prolongation can be increased when Bortezomib is combined with Gemifloxacin.
Progesterone Progesterone The metabolism of Progesterone can be increased when combined with Bortezomib.
Apomorphine Injection Apomorphine Injection The risk or severity of QTc prolongation can be increased when Bortezomib is combined with Apomorphine.
Darbepoetin Alfa Injection Darbepoetin Alfa Injection The risk or severity of Thrombosis can be increased when Darbepoetin alfa is combined with Bortezomib.
Infliximab Injection Infliximab Injection The metabolism of Bortezomib can be increased when combined with Infliximab.
Oxandrolone Oxandrolone The metabolism of Bortezomib can be decreased when combined with Oxandrolone.
Protriptyline Protriptyline The risk or severity of QTc prolongation can be increased when Bortezomib is combined with Protriptyline.
Rifaximin Rifaximin The metabolism of Bortezomib can be increased when combined with Rifaximin.
Duloxetine Duloxetine The metabolism of Bortezomib can be decreased when combined with Duloxetine.
Norethindrone Norethindrone The metabolism of Bortezomib can be decreased when combined with Norethisterone.
Trospium Trospium The metabolism of Bortezomib can be decreased when combined with Trospium.
Bosentan Bosentan The metabolism of Bortezomib can be increased when combined with Bosentan.
Cinacalcet Cinacalcet The metabolism of Bortezomib can be decreased when combined with Cinacalcet.
Natalizumab Injection Natalizumab Injection The risk or severity of adverse effects can be increased when Bortezomib is combined with Natalizumab.
Erlotinib Erlotinib The metabolism of Erlotinib can be decreased when combined with Bortezomib.
Palifermin Palifermin The therapeutic efficacy of Palifermin can be decreased when used in combination with Bortezomib.
Solifenacin Solifenacin The risk or severity of QTc prolongation can be increased when Bortezomib is combined with Solifenacin.
Voriconazole Voriconazole The metabolism of Voriconazole can be decreased when combined with Bortezomib.
Dextroamphetamine Dextroamphetamine The metabolism of Bortezomib can be decreased when combined with Amphetamine.
Entecavir Entecavir The metabolism of Entecavir can be decreased when combined with Bortezomib.
Peginterferon Alfa-2a Injection Peginterferon Alfa-2a Injection The risk or severity of adverse effects can be increased when Peginterferon alfa-2a is combined with Bortezomib.
Peginterferon Alfa-2b (PEG-Intron) Peginterferon Alfa-2b (PEG-Intron) The serum concentration of Bortezomib can be increased when it is combined with Peginterferon alfa-2b.
Ibandronate Ibandronate The risk or severity of QTc prolongation can be increased when Bortezomib is combined with Ibandronate.
Ramelteon Ramelteon The metabolism of Ramelteon can be decreased when combined with Bortezomib.
Darifenacin Darifenacin The metabolism of Darifenacin can be decreased when combined with Bortezomib.
Pregabalin Pregabalin The risk or severity of QTc prolongation can be increased when Bortezomib is combined with Pregabalin.
Deferasirox Deferasirox The serum concentration of Bortezomib can be increased when it is combined with Deferasirox.
Phenylephrine Phenylephrine The metabolism of Bortezomib can be increased when combined with Phenylephrine.
Tipranavir Tipranavir The metabolism of Tipranavir can be decreased when combined with Bortezomib.
Felbamate Felbamate The metabolism of Bortezomib can be increased when combined with Felbamate.
Ranolazine Ranolazine The serum concentration of Bortezomib can be increased when it is combined with Ranolazine.
Abatacept Injection Abatacept Injection The metabolism of Bortezomib can be increased when combined with Abatacept.
Rasagiline Rasagiline The metabolism of Rasagiline can be decreased when combined with Bortezomib.
Imatinib Imatinib The metabolism of Imatinib can be decreased when combined with Bortezomib.
Sitagliptin Sitagliptin The serum concentration of Bortezomib can be increased when it is combined with Sitagliptin.
Bevacizumab Injection Bevacizumab Injection The risk or severity of adverse effects can be increased when Bevacizumab is combined with Bortezomib.
Gefitinib Gefitinib The metabolism of Bortezomib can be decreased when combined with Gefitinib.
Albuterol Albuterol The risk or severity of QTc prolongation can be increased when Bortezomib is combined with Salbutamol.
Paliperidone Paliperidone The serum concentration of Paliperidone can be increased when it is combined with Bortezomib.
Clofarabine Injection Clofarabine Injection The risk or severity of adverse effects can be increased when Bortezomib is combined with Clofarabine.
Hepatitis B Vaccine Hepatitis B Vaccine The therapeutic efficacy of Hepatitis B Vaccine (Recombinant) can be decreased when used in combination with Bortezomib.
Influenza Vaccine, Inactivated or Recombinant Influenza Vaccine, Inactivated or Recombinant The therapeutic efficacy of Corynebacterium diphtheriae toxoid antigen (formaldehyde inactivated) can be decreased when used in combination with Bortezomib.
Influenza Vaccine, Live Intranasal Influenza Vaccine, Live Intranasal The risk or severity of infection can be increased when Typhoid Vaccine Live is combined with Bortezomib.
Live Shingles (Zoster) Vaccine (ZVL) Live Shingles (Zoster) Vaccine (ZVL) The risk or severity of infection can be increased when Varicella Zoster Vaccine (Live/attenuated) is combined with Bortezomib.
Insulin Glulisine (rDNA origin) Injection Insulin Glulisine (rDNA origin) Injection The metabolism of Bortezomib can be increased when combined with Insulin glulisine.
Oxaliplatin Injection Oxaliplatin Injection The risk or severity of adverse effects can be increased when Bortezomib is combined with Oxaliplatin.
Posaconazole Posaconazole The metabolism of Posaconazole can be decreased when combined with Bortezomib.
Primaquine Primaquine The metabolism of Primaquine can be decreased when combined with Bortezomib.
Rituximab Injection Rituximab Injection The risk or severity of adverse effects can be increased when Rituximab is combined with Bortezomib.
Darunavir Darunavir The serum concentration of Bortezomib can be increased when it is combined with Darunavir.
Pemetrexed Injection Pemetrexed Injection The risk or severity of adverse effects can be increased when Bortezomib is combined with Pemetrexed.
Dimenhydrinate Dimenhydrinate The risk or severity of QTc prolongation can be increased when Bortezomib is combined with Dimenhydrinate.
Lisdexamfetamine Lisdexamfetamine The metabolism of Bortezomib can be decreased when combined with Lisdexamfetamine.
Nabilone Nabilone The metabolism of Bortezomib can be decreased when combined with Nabilone.
Vorinostat Vorinostat The risk or severity of adverse effects can be increased when Bortezomib is combined with Vorinostat.
Sorafenib Sorafenib The metabolism of Sorafenib can be decreased when combined with Bortezomib.
Sunitinib Sunitinib The metabolism of Sunitinib can be decreased when combined with Bortezomib.
Dronabinol Dronabinol The metabolism of Dronabinol can be decreased when combined with Bortezomib.
Lapatinib Lapatinib The metabolism of Lapatinib can be decreased when combined with Bortezomib.
Levocetirizine Levocetirizine The risk or severity of QTc prolongation can be increased when Bortezomib is combined with Levocetirizine.
Dasatinib Dasatinib The metabolism of Dasatinib can be decreased when combined with Bortezomib.
Mexiletine Mexiletine The metabolism of Mexiletine can be decreased when combined with Bortezomib.
Armodafinil Armodafinil The metabolism of Bortezomib can be increased when combined with Armodafinil.
Azacitidine Injection Azacitidine Injection The risk or severity of adverse effects can be increased when Bortezomib is combined with Azacitidine.
Ivermectin Ivermectin The metabolism of Bortezomib can be increased when combined with Ivermectin.
Temsirolimus Temsirolimus The serum concentration of Temsirolimus can be increased when it is combined with Bortezomib.
Nelarabine Injection Nelarabine Injection The risk or severity of adverse effects can be increased when Bortezomib is combined with Nelarabine.
Lenalidomide Lenalidomide The risk or severity of adverse effects can be increased when Bortezomib is combined with Lenalidomide.
Nilotinib Nilotinib The metabolism of Nilotinib can be decreased when combined with Bortezomib.
Toremifene Toremifene The serum concentration of Toremifene can be increased when it is combined with Bortezomib.
Bexarotene Bexarotene The metabolism of Bexarotene can be increased when combined with Bortezomib.
Budesonide Budesonide The metabolism of Budesonide can be increased when combined with Bortezomib.
Chloramphenicol Injection Chloramphenicol Injection The metabolism of Chloramphenicol can be decreased when combined with Bortezomib.
Decitabine Injection Decitabine Injection The risk or severity of adverse effects can be increased when Bortezomib is combined with Decitabine.
Etravirine Etravirine The metabolism of Etravirine can be increased when combined with Bortezomib.
Arsenic Trioxide Injection Arsenic Trioxide Injection The risk or severity of adverse effects can be increased when Bortezomib is combined with Arsenic trioxide.
Mitoxantrone Injection Mitoxantrone Injection The metabolism of Mitoxantrone can be decreased when combined with Bortezomib.
Desvenlafaxine Desvenlafaxine The metabolism of Bortezomib can be decreased when combined with Desvenlafaxine.
Cevimeline Cevimeline The metabolism of Bortezomib can be decreased when combined with Cevimeline.
Nebivolol Nebivolol The metabolism of Nebivolol can be decreased when combined with Bortezomib.
Tretinoin Tretinoin The risk or severity of adverse effects can be increased when Bortezomib is combined with Tretinoin.
Bendamustine Injection Bendamustine Injection The risk or severity of adverse effects can be increased when Bortezomib is combined with Bendamustine.
Pilocarpine Pilocarpine The metabolism of Bortezomib can be decreased when combined with Pilocarpine.
Flecainide Flecainide The metabolism of Flecainide can be decreased when combined with Bortezomib.
Certolizumab Injection Certolizumab Injection The metabolism of Bortezomib can be increased when combined with Certolizumab pegol.
Ixabepilone Injection Ixabepilone Injection The risk or severity of adverse effects can be increased when Bortezomib is combined with Ixabepilone.
Irinotecan Injection Irinotecan Injection The risk or severity of adverse effects can be increased when Bortezomib is combined with Irinotecan.
Estramustine Estramustine The risk or severity of adverse effects can be increased when Bortezomib is combined with Estramustine.
Praziquantel Praziquantel The metabolism of Praziquantel can be decreased when combined with Bortezomib.
Mitotane Mitotane The metabolism of Bortezomib can be increased when combined with Mitotane.
Alemtuzumab Injection (Chronic Lymphocytic Leukemia) Alemtuzumab Injection (Chronic Lymphocytic Leukemia) The risk or severity of adverse effects can be increased when Alemtuzumab is combined with Bortezomib.
Rufinamide Rufinamide The metabolism of Bortezomib can be increased when combined with Rufinamide.
Silodosin Silodosin The serum concentration of Bortezomib can be increased when it is combined with Silodosin.
Midazolam Midazolam The metabolism of Bortezomib can be decreased when combined with Midazolam.
Dexrazoxane Injection Dexrazoxane Injection The risk or severity of adverse effects can be increased when Bortezomib is combined with Dexrazoxane.
Eltrombopag Eltrombopag The metabolism of Eltrombopag can be decreased when combined with Bortezomib.
Ibritumomab Injection Ibritumomab Injection The risk or severity of adverse effects can be increased when Ibritumomab tiuxetan is combined with Bortezomib.
Milnacipran Milnacipran The metabolism of Bortezomib can be decreased when combined with Milnacipran.
Dexlansoprazole Dexlansoprazole The metabolism of Dexlansoprazole can be decreased when combined with Bortezomib.
Fesoterodine Fesoterodine The metabolism of Fesoterodine can be decreased when combined with Bortezomib.
Degarelix Injection Degarelix Injection The risk or severity of QTc prolongation can be increased when Bortezomib is combined with Degarelix.
Betaxolol Betaxolol The metabolism of Betaxolol can be decreased when combined with Bortezomib.
Iloperidone Iloperidone The risk or severity of QTc prolongation can be increased when Bortezomib is combined with Iloperidone.
Prasugrel Prasugrel The metabolism of Prasugrel can be decreased when combined with Bortezomib.
Lacosamide Lacosamide The metabolism of Lacosamide can be decreased when combined with Bortezomib.
Everolimus Everolimus The risk or severity of adverse effects can be increased when Everolimus is combined with Bortezomib.
Tolvaptan (low blood sodium) Tolvaptan (low blood sodium) The serum concentration of Bortezomib can be increased when it is combined with Tolvaptan.
Dronedarone Dronedarone The metabolism of Dronedarone can be decreased when combined with Bortezomib.
Pralatrexate Injection Pralatrexate Injection The risk or severity of adverse effects can be increased when Bortezomib is combined with Pralatrexate.
Palonosetron Injection Palonosetron Injection The metabolism of Palonosetron can be decreased when combined with Bortezomib.
Telavancin Injection Telavancin Injection The risk or severity of QTc prolongation can be increased when Bortezomib is combined with Telavancin.
Romidepsin Injection Romidepsin Injection The risk or severity of QTc prolongation can be increased when Bortezomib is combined with Romidepsin.
Tapentadol Tapentadol The metabolism of Tapentadol can be decreased when combined with Bortezomib.
Topotecan Topotecan The metabolism of Topotecan can be increased when combined with Bortezomib.
Golimumab Injection Golimumab Injection The metabolism of Bortezomib can be increased when combined with Golimumab.
Pazopanib Pazopanib The metabolism of Pazopanib can be decreased when combined with Bortezomib.
Asenapine Asenapine The risk or severity of QTc prolongation can be increased when Bortezomib is combined with Asenapine.
Pitavastatin Pitavastatin The metabolism of Pitavastatin can be decreased when combined with Bortezomib.
Albendazole Albendazole The metabolism of Albendazole can be decreased when combined with Bortezomib.
Oxymorphone Oxymorphone The metabolism of Oxymorphone can be decreased when combined with Bortezomib.
Denosumab Injection Denosumab Injection The risk or severity of adverse effects can be increased when Denosumab is combined with Bortezomib.
Dabigatran Dabigatran The risk or severity of bleeding can be increased when Dabigatran is combined with Bortezomib.
Tocilizumab Injection Tocilizumab Injection The metabolism of Bortezomib can be increased when combined with Tocilizumab.
Fingolimod Fingolimod Bortezomib may increase the immunosuppressive activities of Fingolimod.
Eribulin Injection Eribulin Injection The risk or severity of adverse effects can be increased when Bortezomib is combined with Eribulin.
Cabazitaxel Injection Cabazitaxel Injection The risk or severity of adverse effects can be increased when Bortezomib is combined with Cabazitaxel.
Lurasidone Lurasidone The risk or severity of QTc prolongation can be increased when Bortezomib is combined with Lurasidone.
Acetaminophen Injection Acetaminophen Injection The metabolism of Acetaminophen can be increased when combined with Bortezomib.
Vilazodone Vilazodone The metabolism of Bortezomib can be decreased when combined with Vilazodone.
Denileukin Diftitox Injection Denileukin Diftitox Injection The metabolism of Bortezomib can be decreased when combined with Aldesleukin.
Sipuleucel-T Injection Sipuleucel-T Injection The therapeutic efficacy of Sipuleucel-T can be decreased when used in combination with Bortezomib.
Terbutaline Injection Terbutaline Injection The risk or severity of QTc prolongation can be increased when Bortezomib is combined with Terbutaline.
Belimumab Injection Belimumab Injection The risk or severity of adverse effects can be increased when Bortezomib is combined with Belimumab.
Busulfan Injection Busulfan Injection The risk or severity of adverse effects can be increased when Bortezomib is combined with Busulfan.
Roflumilast Roflumilast Roflumilast may increase the immunosuppressive activities of Bortezomib.
Linagliptin Linagliptin The metabolism of Bortezomib can be decreased when combined with Linagliptin.
Rilpivirine Rilpivirine The metabolism of Bortezomib can be decreased when combined with Rilpivirine.
Telaprevir Telaprevir The metabolism of Bortezomib can be decreased when combined with Glecaprevir.
Cyclophosphamide Injection Cyclophosphamide Injection The metabolism of Cyclophosphamide can be increased when combined with Bortezomib.
Abiraterone Abiraterone The serum concentration of Bortezomib can be increased when it is combined with Abiraterone.
Triptorelin Injection Triptorelin Injection The risk or severity of QTc prolongation can be increased when Bortezomib is combined with Triptorelin.
Rivaroxaban Rivaroxaban The serum concentration of Bortezomib can be increased when it is combined with Rivaroxaban.
Ticagrelor Ticagrelor The serum concentration of Bortezomib can be increased when it is combined with Ticagrelor.
Brentuximab Vedotin Injection Brentuximab Vedotin Injection The metabolism of Brentuximab vedotin can be decreased when combined with Bortezomib.
Ruxolitinib Ruxolitinib The risk or severity of adverse effects can be increased when Bortezomib is combined with Ruxolitinib.
Vandetanib Vandetanib The serum concentration of Vandetanib can be increased when it is combined with Bortezomib.
Clobazam Clobazam The metabolism of Bortezomib can be decreased when combined with Clobazam.
Vemurafenib Vemurafenib The serum concentration of Bortezomib can be increased when it is combined with Vemurafenib.
Vismodegib Vismodegib The metabolism of Vismodegib can be decreased when combined with Bortezomib.
Belatacept Injection Belatacept Injection The risk or severity of adverse effects can be increased when Bortezomib is combined with Belatacept.
Ivacaftor Ivacaftor The metabolism of Bortezomib can be decreased when combined with Ivacaftor.
Basiliximab Injection Basiliximab Injection The risk or severity of adverse effects can be increased when Basiliximab is combined with Bortezomib.
Axitinib Axitinib The metabolism of Axitinib can be decreased when combined with Bortezomib.
Crizotinib Crizotinib The metabolism of Crizotinib can be decreased when combined with Bortezomib.
Melphalan Injection Melphalan Injection The risk or severity of adverse effects can be increased when Bortezomib is combined with Melphalan.
Cabergoline Cabergoline The metabolism of Bortezomib can be decreased when combined with Cabergoline.
Naloxone Injection Naloxone Injection The metabolism of Bortezomib can be decreased when combined with Naloxone.
Ambrisentan Ambrisentan The serum concentration of Bortezomib can be increased when it is combined with Ambrisentan.
Eculizumab Injection Eculizumab Injection The risk or severity of adverse effects can be increased when Bortezomib is combined with Eculizumab.
Fondaparinux Injection Fondaparinux Injection The risk or severity of bleeding can be increased when Fondaparinux is combined with Bortezomib.
Pertuzumab Injection Pertuzumab Injection The risk or severity of cardiotoxicity can be increased when Bortezomib is combined with Pertuzumab.
Carfilzomib Injection Carfilzomib Injection The serum concentration of Carfilzomib can be increased when it is combined with Bortezomib.
Iloprost Iloprost The risk or severity of bleeding can be increased when Iloprost is combined with Bortezomib.
Enzalutamide Enzalutamide The metabolism of Enzalutamide can be increased when combined with Bortezomib.
Mirabegron Mirabegron The metabolism of Mirabegron can be decreased when combined with Bortezomib.
Regorafenib Regorafenib The metabolism of Bortezomib can be decreased when combined with Regorafenib.
Bosutinib Bosutinib The metabolism of Bosutinib can be decreased when combined with Bortezomib.
Corticotropin, Repository Injection Corticotropin, Repository Injection The metabolism of Corticotropin can be increased when combined with Bortezomib.
Teriflunomide Teriflunomide The serum concentration of Bortezomib can be decreased when it is combined with Teriflunomide.
Cabozantinib (thyroid cancer) Cabozantinib (thyroid cancer) The metabolism of Cabozantinib can be decreased when combined with Bortezomib.
Bedaquiline Bedaquiline The risk or severity of QTc prolongation can be increased when Bortezomib is combined with Bedaquiline.
Icosapent Ethyl Icosapent Ethyl The risk or severity of bleeding can be increased when Icosapent ethyl is combined with Bortezomib.
Tofacitinib Tofacitinib Bortezomib may increase the immunosuppressive activities of Tofacitinib.
Alogliptin Alogliptin The metabolism of Alogliptin can be decreased when combined with Bortezomib.
Dimethyl Fumarate Dimethyl Fumarate The risk or severity of adverse effects can be increased when Bortezomib is combined with Dimethyl fumarate.
Ponatinib Ponatinib The serum concentration of Ponatinib can be increased when it is combined with Bortezomib.
Pomalidomide Pomalidomide The risk or severity of adverse effects can be increased when Bortezomib is combined with Pomalidomide.
Ado-trastuzumab Emtansine Injection Ado-trastuzumab Emtansine Injection The metabolism of Trastuzumab emtansine can be decreased when combined with Bortezomib.
Apixaban Apixaban The metabolism of Apixaban can be decreased when combined with Bortezomib.
Canagliflozin Canagliflozin The serum concentration of Bortezomib can be increased when it is combined with Canagliflozin.
Dabrafenib Dabrafenib The metabolism of Bortezomib can be increased when combined with Dabrafenib.
Ospemifene Ospemifene The metabolism of Ospemifene can be decreased when combined with Bortezomib.
Trametinib Trametinib The metabolism of Bortezomib can be increased when combined with Trametinib.
Dolutegravir Dolutegravir The serum concentration of Bortezomib can be increased when it is combined with Dolutegravir.
Afatinib Afatinib The serum concentration of Bortezomib can be increased when it is combined with Afatinib.
Levomilnacipran Levomilnacipran The metabolism of Levomilnacipran can be decreased when combined with Bortezomib.
Vortioxetine Vortioxetine The metabolism of Vortioxetine can be decreased when combined with Bortezomib.
Perampanel Perampanel The metabolism of Perampanel can be increased when combined with Bortezomib.
Ibrutinib Ibrutinib The risk or severity of adverse effects can be increased when Bortezomib is combined with Ibrutinib.
Lomitapide Lomitapide The metabolism of Bortezomib can be decreased when combined with Lomitapide.
Ketorolac Injection Ketorolac Injection The metabolism of Ketorolac can be decreased when combined with Bortezomib.
Obinutuzumab Injection Obinutuzumab Injection The risk or severity of adverse effects can be increased when Bortezomib is combined with Obinutuzumab.
Simeprevir Simeprevir The metabolism of Bortezomib can be decreased when combined with Simeprevir.
Sofosbuvir Sofosbuvir The serum concentration of Bortezomib can be increased when it is combined with Sofosbuvir.
Dapagliflozin Dapagliflozin The metabolism of Bortezomib can be decreased when combined with Dapagliflozin.
Apremilast Apremilast The metabolism of Bortezomib can be increased when combined with Apremilast.
Ceritinib Ceritinib The metabolism of Bortezomib can be decreased when combined with Ceritinib.
Siltuximab Injection Siltuximab Injection The metabolism of Bortezomib can be increased when combined with Siltuximab.
Eslicarbazepine Eslicarbazepine The metabolism of Bortezomib can be increased when combined with Eslicarbazepine.
Vedolizumab Injection Vedolizumab Injection The risk or severity of adverse effects can be increased when Bortezomib is combined with Vedolizumab.
Belinostat Injection Belinostat Injection The risk or severity of adverse effects can be increased when Bortezomib is combined with Belinostat.
Idelalisib Idelalisib The risk or severity of adverse effects can be increased when Bortezomib is combined with Idelalisib.
Testosterone Injection Testosterone Injection The metabolism of Testosterone can be increased when combined with Bortezomib.
Oritavancin Injection Oritavancin Injection The metabolism of Bortezomib can be increased when combined with Oritavancin.
Vorapaxar Vorapaxar The serum concentration of Bortezomib can be increased when it is combined with Vorapaxar.
Suvorexant Suvorexant The serum concentration of Bortezomib can be increased when it is combined with Suvorexant.
Edoxaban Edoxaban The serum concentration of Bortezomib can be increased when it is combined with Edoxaban.
Peginterferon Beta-1a Injection Peginterferon Beta-1a Injection The risk or severity of adverse effects can be increased when Bortezomib is combined with Peginterferon beta-1a.
Olaparib Olaparib The metabolism of Olaparib can be decreased when combined with Bortezomib.
Blinatumomab Injection Blinatumomab Injection The risk or severity of adverse effects can be increased when Bortezomib is combined with Blinatumomab.
Methamphetamine Methamphetamine The metabolism of Metamfetamine can be decreased when combined with Bortezomib.
Tasimelteon Tasimelteon The metabolism of Tasimelteon can be decreased when combined with Bortezomib.
Lanreotide Injection Lanreotide Injection The metabolism of Bortezomib can be decreased when combined with Lanreotide.
Pirfenidone Pirfenidone The risk or severity of adverse effects can be increased when Pirfenidone is combined with Bortezomib.
Nintedanib Nintedanib The metabolism of Bortezomib can be decreased when combined with Nintedanib.
Secukinumab Injection Secukinumab Injection The metabolism of Bortezomib can be increased when combined with Secukinumab.
Risperidone Injection Risperidone Injection The risk or severity of QTc prolongation can be increased when Bortezomib is combined with Risperidone.
Palbociclib Palbociclib The metabolism of Palbociclib can be decreased when combined with Bortezomib.
Insulin Human Inhalation Insulin Human Inhalation The metabolism of Bortezomib can be increased when combined with Insulin human.
Lenvatinib Lenvatinib The metabolism of Lenvatinib can be increased when combined with Bortezomib.
Naloxegol Naloxegol The metabolism of Bortezomib can be decreased when combined with Naloxegol.
Panobinostat Panobinostat The metabolism of Panobinostat can be decreased when combined with Bortezomib.
Dinutuximab Injection Dinutuximab Injection The risk or severity of adverse effects can be increased when Bortezomib is combined with Dinutuximab.
Haloperidol Injection Haloperidol Injection The risk or severity of QTc prolongation can be increased when Bortezomib is combined with Haloperidol.
Ivabradine Ivabradine The risk or severity of QTc prolongation can be increased when Bortezomib is combined with Ivabradine.
Isavuconazonium Injection Isavuconazonium Injection The serum concentration of Bortezomib can be increased when it is combined with Isavuconazonium.
Flibanserin Flibanserin The serum concentration of Bortezomib can be increased when it is combined with Flibanserin.
Rolapitant Rolapitant The metabolism of Bortezomib can be decreased when combined with Rolapitant.
Prednisolone Prednisolone The metabolism of Prednisolone can be increased when combined with Bortezomib.
Daclatasvir Daclatasvir The serum concentration of Bortezomib can be increased when it is combined with Daclatasvir.
Brexpiprazole Brexpiprazole The metabolism of Brexpiprazole can be decreased when combined with Bortezomib.
Ziprasidone Injection Ziprasidone Injection The risk or severity of QTc prolongation can be increased when Bortezomib is combined with Ziprasidone.
Cariprazine Cariprazine The metabolism of Cariprazine can be decreased when combined with Bortezomib.
Insulin Degludec (rDNA Origin) Injection Insulin Degludec (rDNA Origin) Injection The metabolism of Bortezomib can be increased when combined with Insulin degludec.
Cobimetinib Cobimetinib The metabolism of Bortezomib can be decreased when combined with Cobimetinib.
Mepolizumab Injection Mepolizumab Injection The risk or severity of adverse effects can be increased when Bortezomib is combined with Mepolizumab.
Trabectedin Injection Trabectedin Injection The metabolism of Trabectedin can be decreased when combined with Bortezomib.
Osimertinib Osimertinib The serum concentration of Bortezomib can be decreased when it is combined with Osimertinib.
Rifapentine Rifapentine The metabolism of Bortezomib can be increased when combined with Rifapentine.
Lesinurad Lesinurad The metabolism of Lesinurad can be increased when combined with Bortezomib.
Amphotericin B Liposomal Injection Amphotericin B Liposomal Injection The metabolism of Amphotericin B can be decreased when combined with Bortezomib.
Dexamethasone Injection Dexamethasone Injection The metabolism of Dexamethasone can be increased when combined with Bortezomib.
Defibrotide Injection Defibrotide Injection The risk or severity of bleeding can be increased when Defibrotide is combined with Bortezomib.
Ixekizumab Injection Ixekizumab Injection The risk or severity of adverse effects can be increased when Bortezomib is combined with Ixekizumab.
Brivaracetam Injection Brivaracetam Injection The metabolism of Brivaracetam can be decreased when combined with Bortezomib.
Venetoclax Venetoclax The metabolism of Bortezomib can be decreased when combined with Venetoclax.
Cobicistat Cobicistat The metabolism of Bortezomib can be decreased when combined with Cobicistat.
Selexipag Selexipag The serum concentration of Bortezomib can be increased when it is combined with Selexipag.
Obeticholic Acid Obeticholic Acid The metabolism of Bortezomib can be decreased when combined with Obeticholic acid.
Diphenhydramine Injection Diphenhydramine Injection The risk or severity of QTc prolongation can be increased when Bortezomib is combined with Diphenhydramine.
Rucaparib Rucaparib The metabolism of Rucaparib can be decreased when combined with Bortezomib.
Ribociclib Ribociclib The metabolism of Ribociclib can be decreased when combined with Bortezomib.
Brodalumab Injection Brodalumab Injection The risk or severity of adverse effects can be increased when Bortezomib is combined with Brodalumab.
Brigatinib Brigatinib The metabolism of Bortezomib can be increased when combined with Brigatinib.
Doxepin (Insomnia) Doxepin (Insomnia) The risk or severity of QTc prolongation can be increased when Bortezomib is combined with Doxepin.
Deutetrabenazine Deutetrabenazine The risk or severity of QTc prolongation can be increased when Bortezomib is combined with Deutetrabenazine.
Valbenazine Valbenazine The metabolism of Valbenazine can be decreased when combined with Bortezomib.
Deflazacort Deflazacort The metabolism of Deflazacort can be increased when combined with Bortezomib.
Safinamide Safinamide The metabolism of Bortezomib can be decreased when combined with Safinamide.
Ocrelizumab Injection Ocrelizumab Injection Ocrelizumab may increase the immunosuppressive activities of Bortezomib.
Sarilumab Injection Sarilumab Injection The metabolism of Sarilumab can be increased when combined with Bortezomib.
Midostaurin Midostaurin The metabolism of Bortezomib can be increased when combined with Midostaurin.
Neratinib Neratinib The serum concentration of Bortezomib can be increased when it is combined with Neratinib.
Guselkumab Injection Guselkumab Injection The risk or severity of adverse effects can be increased when Bortezomib is combined with Guselkumab.
Enasidenib Enasidenib The serum concentration of Bortezomib can be increased when it is combined with Enasidenib.
Inotuzumab Ozogamicin Injection Inotuzumab Ozogamicin Injection The serum concentration of Bortezomib can be increased when it is combined with Inotuzumab ozogamicin.
Aprepitant/Fosaprepitant Injection Aprepitant/Fosaprepitant Injection The metabolism of Bortezomib can be increased when combined with Fosaprepitant.
Copanlisib Injection Copanlisib Injection The serum concentration of Copanlisib can be increased when it is combined with Bortezomib.
Delafloxacin Delafloxacin The risk or severity of QTc prolongation can be increased when Delafloxacin is combined with Bortezomib.
Abemaciclib Abemaciclib The serum concentration of Abemaciclib can be increased when it is combined with Bortezomib.
Betrixaban Betrixaban The serum concentration of Bortezomib can be increased when it is combined with Betrixaban.
Acalabrutinib Acalabrutinib The metabolism of Bortezomib can be decreased when combined with Acalabrutinib.
Gemtuzumab Ozogamicin Injection Gemtuzumab Ozogamicin Injection The risk or severity of adverse effects can be increased when Gemtuzumab ozogamicin is combined with Bortezomib.
Letermovir Letermovir The metabolism of Letermovir can be decreased when combined with Bortezomib.
Tetrabenazine Tetrabenazine The risk or severity of QTc prolongation can be increased when Bortezomib is combined with Tetrabenazine.
Ertugliflozin Ertugliflozin The serum concentration of Bortezomib can be increased when it is combined with Ertugliflozin.
Buprenorphine Injection Buprenorphine Injection The metabolism of Buprenorphine can be decreased when combined with Bortezomib.
Apalutamide Apalutamide The metabolism of Bortezomib can be increased when combined with Apalutamide.
Penicillamine Penicillamine The risk or severity of adverse effects can be increased when Bortezomib is combined with Penicillamine.
Fostamatinib Fostamatinib The metabolism of Bortezomib can be decreased when combined with Fostamatinib.
Avatrombopag Avatrombopag The serum concentration of Bortezomib can be increased when it is combined with Avatrombopag.
Baricitinib Baricitinib The risk or severity of adverse effects can be increased when Bortezomib is combined with Baricitinib.
Lofexidine Lofexidine The metabolism of Lofexidine can be decreased when combined with Bortezomib.
Eliglustat Eliglustat The serum concentration of Bortezomib can be increased when it is combined with Eliglustat.
Encorafenib Encorafenib The risk or severity of QTc prolongation can be increased when Bortezomib is combined with Encorafenib.
Binimetinib Binimetinib The metabolism of Binimetinib can be decreased when combined with Bortezomib.
Ivosidenib Ivosidenib The metabolism of Ivosidenib can be increased when combined with Bortezomib.
Lusutrombopag Lusutrombopag The serum concentration of Bortezomib can be increased when it is combined with Lusutrombopag.
Elagolix Elagolix The serum concentration of Elagolix can be increased when it is combined with Bortezomib.
Tafenoquine Tafenoquine The metabolism of Tafenoquine can be decreased when combined with Bortezomib.
Cannabidiol Cannabidiol The metabolism of Bortezomib can be decreased when combined with Cannabidiol.
Dacomitinib Dacomitinib The metabolism of Bortezomib can be decreased when combined with Dacomitinib.
Duvelisib Duvelisib The metabolism of Bortezomib can be decreased when combined with Duvelisib.
Omadacycline Omadacycline The serum concentration of Bortezomib can be increased when it is combined with Omadacycline.
Sarecycline Sarecycline The serum concentration of Bortezomib can be increased when it is combined with Sarecycline.
Stiripentol Stiripentol The metabolism of Bortezomib can be decreased when combined with Stiripentol.
Talazoparib Talazoparib The serum concentration of Talazoparib can be increased when it is combined with Bortezomib.
Gilteritinib Gilteritinib The metabolism of Gilteritinib can be decreased when combined with Bortezomib.
Glasdegib Glasdegib The serum concentration of Glasdegib can be increased when it is combined with Bortezomib.
Lorlatinib Lorlatinib The metabolism of Lorlatinib can be decreased when combined with Bortezomib.
Larotrectinib Larotrectinib The serum concentration of Bortezomib can be increased when it is combined with Larotrectinib.
Methoxy Polyethylene Glycol-Epoetin Beta Injection Methoxy Polyethylene Glycol-Epoetin Beta Injection The risk or severity of Thrombosis can be increased when Methoxy polyethylene glycol-epoetin beta is combined with Bortezomib.
Paclitaxel (with albumin) Injection Paclitaxel (with albumin) Injection The metabolism of Paclitaxel can be increased when combined with Bortezomib.
Rifamycin Rifamycin The metabolism of Bortezomib can be increased when combined with Rifamycin.
Prucalopride Prucalopride The metabolism of Bortezomib can be decreased when combined with Prucalopride.
Ravulizumab-cwvz Injection Ravulizumab-cwvz Injection The risk or severity of adverse effects can be increased when Bortezomib is combined with Ravulizumab.
Emapalumab-lzsg Injection Emapalumab-lzsg Injection The metabolism of Bortezomib can be increased when combined with Emapalumab.
Siponimod Siponimod The metabolism of Siponimod can be decreased when combined with Bortezomib.
Acyclovir Ophthalmic Acyclovir Ophthalmic The metabolism of Acyclovir can be decreased when combined with Bortezomib.
Caplacizumab-yhdp Injection Caplacizumab-yhdp Injection The risk or severity of bleeding can be increased when Caplacizumab is combined with Bortezomib.
Erdafitinib Erdafitinib The serum concentration of Erdafitinib can be increased when it is combined with Bortezomib.
Esomeprazole Injection Esomeprazole Injection The metabolism of Esomeprazole can be decreased when combined with Bortezomib.
Risankizumab-rzaa Injection Risankizumab-rzaa Injection The risk or severity of adverse effects can be increased when Bortezomib is combined with Risankizumab.
Alpelisib Alpelisib The serum concentration of Bortezomib can be decreased when it is combined with Alpelisib.
Cladribine Cladribine The risk or severity of adverse effects can be increased when Bortezomib is combined with Cladribine.
Darolutamide Darolutamide The serum concentration of Bortezomib can be increased when it is combined with Darolutamide.
Triclabendazole Triclabendazole The metabolism of Triclabendazole can be decreased when combined with Bortezomib.
Entrectinib Entrectinib The risk or severity of QTc prolongation can be increased when Bortezomib is combined with Entrectinib.
Pexidartinib Pexidartinib Bortezomib may increase the hepatotoxic activities of Pexidartinib.
Istradefylline Istradefylline The serum concentration of Istradefylline can be increased when it is combined with Bortezomib.
Pitolisant Pitolisant The serum concentration of Bortezomib can be decreased when it is combined with Pitolisant.
Fedratinib Fedratinib The serum concentration of Fedratinib can be increased when it is combined with Bortezomib.
Lefamulin Lefamulin Lefamulin may increase the QTc-prolonging activities of Bortezomib.
Phenytoin Injection Phenytoin Injection The metabolism of Bortezomib can be increased when combined with Phenytoin.
Fosphenytoin Injection Fosphenytoin Injection The metabolism of Bortezomib can be increased when combined with Fosphenytoin.
Enfortumab vedotin-ejfv Injection Enfortumab vedotin-ejfv Injection The serum concentration of Bortezomib can be increased when it is combined with Enfortumab vedotin.
Voxelotor Voxelotor The serum concentration of Voxelotor can be increased when it is combined with Bortezomib.
Avapritinib Avapritinib The metabolism of Avapritinib can be decreased when combined with Bortezomib.
Lasmiditan Lasmiditan The serum concentration of Bortezomib can be increased when it is combined with Lasmiditan.
Ubrogepant Ubrogepant The serum concentration of Bortezomib can be increased when it is combined with Ubrogepant.
Tazemetostat Tazemetostat The metabolism of Bortezomib can be decreased when combined with Tazemetostat.
Cenobamate Cenobamate The serum concentration of Cenobamate can be decreased when it is combined with Bortezomib.
Ozanimod Ozanimod The risk or severity of adverse effects can be increased when Bortezomib is combined with Ozanimod.
Selumetinib Selumetinib The metabolism of Selumetinib can be decreased when combined with Bortezomib.
Rimegepant Rimegepant The serum concentration of Bortezomib can be increased when it is combined with Rimegepant.
Tucatinib Tucatinib The metabolism of Tucatinib can be decreased when combined with Bortezomib.
Remdesivir Injection Remdesivir Injection The serum concentration of Bortezomib can be increased when it is combined with Remdesivir.
Ripretinib Ripretinib The serum concentration of Bortezomib can be increased when it is combined with Ripretinib.
Capmatinib Capmatinib The serum concentration of Bortezomib can be increased when it is combined with Capmatinib.
Lemborexant Lemborexant The serum concentration of Bortezomib can be increased when it is combined with Lemborexant.
Fenfluramine Fenfluramine The metabolism of Bortezomib can be decreased when combined with Fenfluramine.
Fostemsavir Fostemsavir The risk or severity of QTc prolongation can be increased when Bortezomib is combined with Fostemsavir.
Octreotide Octreotide The serum concentration of Bortezomib can be increased when it is combined with Octreotide.
Belantamab Mafodotin-blmf Injection Belantamab Mafodotin-blmf Injection The serum concentration of Bortezomib can be increased when it is combined with Belantamab mafodotin.
Pralsetinib Pralsetinib The serum concentration of Bortezomib can be increased when it is combined with Pralsetinib.
Satralizumab-mwge Injection Satralizumab-mwge Injection The serum concentration of Bortezomib can be decreased when it is combined with Satralizumab.
Relugolix Relugolix The risk or severity of QTc prolongation can be increased when Bortezomib is combined with Relugolix.
Progestin-Only (drospirenone) Oral Contraceptives Progestin-Only (drospirenone) Oral Contraceptives The metabolism of Bortezomib can be decreased when combined with Drospirenone.
Viloxazine Viloxazine The metabolism of Bortezomib can be decreased when combined with Viloxazine.
Vitamin E (Alpha-Tocopherol) Vitamin E (Alpha-Tocopherol) The metabolism of Bortezomib can be increased when combined with Vitamin E.
Theophylline Theophylline The metabolism of Theophylline can be decreased when combined with Bortezomib.
Indomethacin Indomethacin The risk or severity of adverse effects can be increased when Bortezomib is combined with Indomethacin.
Mefenamic Acid Mefenamic Acid The metabolism of Mefenamic acid can be decreased when combined with Bortezomib.
Naproxen Naproxen The metabolism of Naproxen can be decreased when combined with Bortezomib.
Trazodone Trazodone The risk or severity of QTc prolongation can be increased when Trazodone is combined with Bortezomib.
Hydroxyurea Hydroxyurea The risk or severity of adverse effects can be increased when Bortezomib is combined with Hydroxyurea.
Floxuridine Floxuridine The risk or severity of adverse effects can be increased when Bortezomib is combined with Floxuridine.
Phenobarbital Phenobarbital The metabolism of Phenobarbital can be increased when combined with Bortezomib.
Methotrexate Injection Methotrexate Injection The risk or severity of adverse effects can be increased when Bortezomib is combined with Methotrexate.
Primidone Primidone The metabolism of Primidone can be increased when combined with Bortezomib.
Methsuximide Methsuximide The metabolism of Methsuximide can be decreased when combined with Bortezomib.
Chlorpromazine Chlorpromazine The metabolism of Chlorpromazine can be decreased when combined with Bortezomib.
Diazepam Diazepam The metabolism of Diazepam can be decreased when combined with Bortezomib.
Lorazepam Lorazepam The metabolism of Bortezomib can be decreased when combined with Lorazepam.
Carmustine Carmustine The risk or severity of adverse effects can be increased when Bortezomib is combined with Carmustine.
Amantadine Amantadine The risk or severity of QTc prolongation can be increased when Bortezomib is combined with Amantadine.
Codeine Codeine The metabolism of Codeine can be decreased when combined with Bortezomib.
Bromocriptine Bromocriptine The metabolism of Bromocriptine can be decreased when combined with Bortezomib.
Tranylcypromine Tranylcypromine The metabolism of Bortezomib can be decreased when combined with Tranylcypromine.
Phenelzine Phenelzine The metabolism of Bortezomib can be decreased when combined with Phenelzine.
Procarbazine Procarbazine The risk or severity of adverse effects can be increased when Bortezomib is combined with Procarbazine.
Tetracycline Tetracycline The metabolism of Bortezomib can be decreased when combined with Tetracycline.
Thioguanine Thioguanine The risk or severity of adverse effects can be increased when Bortezomib is combined with Tioguanine.
Prochlorperazine Prochlorperazine The metabolism of Prochlorperazine can be decreased when combined with Bortezomib.
Thioridazine Thioridazine The metabolism of Bortezomib can be decreased when combined with Thioridazine.
Trifluoperazine Trifluoperazine The metabolism of Trifluoperazine can be decreased when combined with Bortezomib.
Bleomycin Bleomycin The risk or severity of adverse effects can be increased when Bortezomib is combined with Bleomycin.
Dapsone Dapsone The metabolism of Dapsone can be decreased when combined with Bortezomib.
Sulfadiazine Sulfadiazine The metabolism of Bortezomib can be decreased when combined with Sulfadiazine.
Oxycodone Oxycodone The metabolism of Oxycodone can be decreased when combined with Bortezomib.
Methadone Methadone The metabolism of Methadone can be increased when combined with Bortezomib.
Oxybutynin Oxybutynin The metabolism of Bortezomib can be decreased when combined with Oxybutynin.
Benztropine Benztropine The risk or severity of QTc prolongation can be increased when Bortezomib is combined with Benzatropine.
Maprotiline Maprotiline The metabolism of Maprotiline can be decreased when combined with Bortezomib.
Ibuprofen Ibuprofen The metabolism of Ibuprofen can be decreased when combined with Bortezomib.
Orphenadrine Orphenadrine The metabolism of Bortezomib can be decreased when combined with Orphenadrine.
Perphenazine Perphenazine The metabolism of Perphenazine can be decreased when combined with Bortezomib.
Azathioprine Azathioprine The risk or severity of adverse effects can be increased when Bortezomib is combined with Azathioprine.
Fluphenazine Fluphenazine The metabolism of Bortezomib can be decreased when combined with Fluphenazine.
Phentermine Phentermine The metabolism of Bortezomib can be decreased when combined with Phentermine.
Amoxapine Amoxapine The metabolism of Amoxapine can be decreased when combined with Bortezomib.
Sulfasalazine Sulfasalazine The risk or severity of adverse effects can be increased when Bortezomib is combined with Sulfasalazine.
Hydrocortisone Hydrocortisone The metabolism of Bortezomib can be increased when combined with Hydrocortisone.
Lomustine Lomustine The risk or severity of adverse effects can be increased when Bortezomib is combined with Lomustine.
Doxorubicin Doxorubicin The metabolism of Doxorubicin can be decreased when combined with Bortezomib.
Cytarabine Cytarabine The risk or severity of adverse effects can be increased when Bortezomib is combined with Cytarabine.
Mechlorethamine Mechlorethamine The risk or severity of adverse effects can be increased when Bortezomib is combined with Mechlorethamine.
Dactinomycin Dactinomycin The risk or severity of adverse effects can be increased when Bortezomib is combined with Dactinomycin.
Carbamazepine Carbamazepine The metabolism of Bortezomib can be increased when combined with Carbamazepine.
Clonidine Clonidine The metabolism of Clonidine can be decreased when combined with Bortezomib.
Hydralazine Hydralazine The metabolism of Hydralazine can be decreased when combined with Bortezomib.
Cimetidine Cimetidine The metabolism of Cimetidine can be decreased when combined with Bortezomib.
Warfarin Warfarin The metabolism of Warfarin can be increased when combined with Bortezomib.
Loperamide Loperamide The metabolism of Loperamide can be decreased when combined with Bortezomib.
Promethazine Promethazine The metabolism of Bortezomib can be decreased when combined with Promethazine.
Daunorubicin Daunorubicin The metabolism of Daunorubicin can be decreased when combined with Bortezomib.
Griseofulvin Griseofulvin The metabolism of Bortezomib can be increased when combined with Griseofulvin.
Digoxin Digoxin The risk or severity of QTc prolongation can be increased when Digoxin is combined with Bortezomib.
Loxapine Loxapine The serum concentration of Bortezomib can be increased when it is combined with Loxapine.
Chloroquine Chloroquine The metabolism of Bortezomib can be decreased when combined with Chloroquine.
Quinine Quinine The metabolism of Quinine can be decreased when combined with Bortezomib.
Ethosuximide Ethosuximide The risk or severity of QTc prolongation can be increased when Bortezomib is combined with Ethosuximide.
Calcitriol Calcitriol The metabolism of Bortezomib can be increased when combined with Calcitriol.
Triamterene Triamterene The metabolism of Triamterene can be decreased when combined with Bortezomib.
Sulfinpyrazone Sulfinpyrazone The metabolism of Bortezomib can be increased when combined with Sulfinpyrazone.
Chlorothiazide Chlorothiazide The risk or severity of neutropenia and thrombocytopenia can be increased when Chlorothiazide is combined with Bortezomib.
Secobarbital Secobarbital The metabolism of Bortezomib can be increased when combined with Secobarbital.
Desipramine Desipramine The metabolism of Desipramine can be decreased when combined with Bortezomib.
Amitriptyline Amitriptyline The metabolism of Amitriptyline can be decreased when combined with Bortezomib.
Imipramine Imipramine The metabolism of Imipramine can be decreased when combined with Bortezomib.
Probenecid Probenecid The metabolism of Bortezomib can be increased when combined with Probenecid.
Quinidine Quinidine The serum concentration of Bortezomib can be increased when it is combined with Quinidine.
Procainamide Procainamide The metabolism of Procainamide can be decreased when combined with Bortezomib.
Isoniazid Isoniazid The metabolism of Bortezomib can be decreased when combined with Isoniazid.
Rifampin Rifampin The metabolism of Bortezomib can be increased when combined with Rifampicin.
Disopyramide Disopyramide The risk or severity of QTc prolongation can be increased when Bortezomib is combined with Disopyramide.
Valproic Acid Valproic Acid The metabolism of Valproic acid can be decreased when combined with Bortezomib.
Tamoxifen Tamoxifen The metabolism of Tamoxifen can be increased when combined with Bortezomib.
Mitomycin Mitomycin The risk or severity of adverse effects can be increased when Bortezomib is combined with Mitomycin.
Levothyroxine Levothyroxine The serum concentration of Bortezomib can be decreased when it is combined with Levothyroxine.
Methimazole Methimazole The metabolism of Methimazole can be decreased when combined with Bortezomib.
Propylthiouracil Propylthiouracil The risk or severity of adverse effects can be increased when Bortezomib is combined with Propylthiouracil.
Chlorpropamide Chlorpropamide The metabolism of Chlorpropamide can be decreased when combined with Bortezomib.
Tolbutamide Tolbutamide The metabolism of Tolbutamide can be decreased when combined with Bortezomib.
Tolazamide Tolazamide The metabolism of Tolazamide can be decreased when combined with Bortezomib.
Dextromethorphan Dextromethorphan The metabolism of Dextromethorphan can be decreased when combined with Bortezomib.
Cyclobenzaprine Cyclobenzaprine The metabolism of Cyclobenzaprine can be decreased when combined with Bortezomib.
Niacin Niacin The metabolism of Bortezomib can be decreased when combined with Niacin.
Doxylamine Doxylamine The risk or severity of QTc prolongation can be increased when Bortezomib is combined with Doxylamine.
Cyproheptadine Cyproheptadine The risk or severity of QTc prolongation can be increased when Bortezomib is combined with Cyproheptadine.
Clemastine Clemastine The risk or severity of QTc prolongation can be increased when Bortezomib is combined with Clemastine.
Chlorpheniramine Chlorpheniramine The risk or severity of QTc prolongation can be increased when Bortezomib is combined with Chlorpheniramine.
Brompheniramine Brompheniramine The risk or severity of QTc prolongation can be increased when Bortezomib is combined with Dexbrompheniramine.
Meclizine Meclizine The metabolism of Meclizine can be decreased when combined with Bortezomib.
Methyclothiazide Methyclothiazide The risk or severity of neutropenia and thrombocytopenia can be increased when Methyclothiazide is combined with Bortezomib.
Hydrochlorothiazide Hydrochlorothiazide The risk or severity of QTc prolongation can be increased when Bortezomib is combined with Hydrochlorothiazide.
Chlorzoxazone Chlorzoxazone The metabolism of Chlorzoxazone can be decreased when combined with Bortezomib.
Carisoprodol Carisoprodol The metabolism of Carisoprodol can be decreased when combined with Bortezomib.
Danazol Danazol The metabolism of Bortezomib can be decreased when combined with Danazol.
Disulfiram Disulfiram The risk or severity of QTc prolongation can be increased when Bortezomib is combined with Disulfiram.
Propranolol (Cardiovascular) Propranolol (Cardiovascular) The serum concentration of Propranolol can be increased when it is combined with Bortezomib.
Nortriptyline Nortriptyline The metabolism of Nortriptyline can be decreased when combined with Bortezomib.
Amphotericin B Injection Amphotericin B Injection The metabolism of Amphotericin B can be decreased when combined with Bortezomib.
Mercaptopurine Mercaptopurine The risk or severity of adverse effects can be increased when Bortezomib is combined with Mercaptopurine.
Nadolol Nadolol The metabolism of Nadolol can be decreased when combined with Bortezomib.
Allopurinol Allopurinol The risk or severity of adverse effects can be increased when Allopurinol is combined with Bortezomib.
Oxytocin Injection Oxytocin Injection The risk or severity of QTc prolongation can be increased when Oxytocin is combined with Bortezomib.
Clomiphene Clomiphene The serum concentration of Bortezomib can be increased when it is combined with Clomifene.
Papaverine Papaverine The risk or severity of QTc prolongation can be increased when Bortezomib is combined with Papaverine.
Fluorouracil Injection Fluorouracil Injection The risk or severity of adverse effects can be increased when Bortezomib is combined with Fluorouracil.
Colchicine Colchicine The metabolism of Bortezomib can be increased when combined with Colchicine.
Cephalexin Cephalexin The metabolism of Bortezomib can be decreased when combined with Cephalexin.
Dacarbazine Dacarbazine The risk or severity of adverse effects can be increased when Bortezomib is combined with Dacarbazine.
Acetazolamide Acetazolamide The metabolism of Bortezomib can be decreased when combined with Acetazolamide.
Bacillus Calmette-Guerin (BCG) Vaccine Bacillus Calmette-Guerin (BCG) Vaccine The risk or severity of infection can be increased when Bacillus calmette-guerin substrain tice live antigen is combined with Bortezomib.
Ketoconazole Ketoconazole The metabolism of Bortezomib can be decreased when combined with Ketoconazole.
Thiotepa Injection Thiotepa Injection The risk or severity of adverse effects can be increased when Bortezomib is combined with Thiotepa.
Vincristine Injection Vincristine Injection The risk or severity of adverse effects can be increased when Bortezomib is combined with Vincristine.
Dipyridamole Dipyridamole The risk or severity of bleeding can be increased when Dipyridamole is combined with Bortezomib.
Vinblastine Vinblastine The metabolism of Vinblastine can be increased when combined with Bortezomib.
Metoprolol Metoprolol The metabolism of Bortezomib can be decreased when combined with Metoprolol.
Hydroxyzine Hydroxyzine The risk or severity of QTc prolongation can be increased when Hydroxyzine is combined with Bortezomib.
Thiothixene Thiothixene The metabolism of Thiothixene can be decreased when combined with Bortezomib.
Aspirin Aspirin The metabolism of Acetylsalicylic acid can be decreased when combined with Bortezomib.
Chlorambucil Chlorambucil The risk or severity of adverse effects can be increased when Bortezomib is combined with Chlorambucil.
Hyoscyamine Hyoscyamine The risk or severity of QTc prolongation can be increased when Bortezomib is combined with Hyoscyamine.
Trimethoprim Trimethoprim The metabolism of Trimethoprim can be decreased when combined with Bortezomib.
Diltiazem Diltiazem The metabolism of Diltiazem can be decreased when combined with Bortezomib.
Nifedipine Nifedipine The metabolism of Nifedipine can be increased when combined with Bortezomib.
Timolol Timolol The metabolism of Timolol can be decreased when combined with Bortezomib.
Verapamil Verapamil The metabolism of Verapamil can be decreased when combined with Bortezomib.
Atenolol Atenolol The metabolism of Atenolol can be decreased when combined with Bortezomib.
Pindolol Pindolol The metabolism of Bortezomib can be decreased when combined with Pindolol.
Cisplatin Injection Cisplatin Injection The risk or severity of adverse effects can be increased when Bortezomib is combined with Cisplatin.
Piroxicam Piroxicam The metabolism of Piroxicam can be decreased when combined with Bortezomib.
Streptozocin Streptozocin The risk or severity of adverse effects can be increased when Bortezomib is combined with Streptozocin.
Etoposide Etoposide The metabolism of Etoposide can be increased when combined with Bortezomib.
Glyburide Glyburide The metabolism of Glyburide can be decreased when combined with Bortezomib.
Glipizide Glipizide The metabolism of Glipizide can be decreased when combined with Bortezomib.
Indapamide Indapamide The risk or severity of QTc prolongation can be increased when Bortezomib is combined with Indapamide.
Dicloxacillin Dicloxacillin The metabolism of Bortezomib can be increased when combined with Dicloxacillin.
Nafcillin Injection Nafcillin Injection The metabolism of Bortezomib can be increased when combined with Nafcillin.
Pentoxifylline Pentoxifylline The metabolism of Pentoxifylline can be decreased when combined with Bortezomib.
Pentamidine Injection Pentamidine Injection The risk or severity of QTc prolongation can be increased when Bortezomib is combined with Pentamidine.
Labetalol Labetalol The metabolism of Bortezomib can be decreased when combined with Labetalol.
Leuprolide Injection Leuprolide Injection The risk or severity of QTc prolongation can be increased when Bortezomib is combined with Leuprolide.
Gemfibrozil Gemfibrozil The metabolism of Bortezomib can be decreased when combined with Gemfibrozil.
Guanabenz Guanabenz The metabolism of Guanabenz can be decreased when combined with Bortezomib.
Pimozide Pimozide The metabolism of Bortezomib can be decreased when combined with Pimozide.
Flurbiprofen Flurbiprofen The metabolism of Flurbiprofen can be decreased when combined with Bortezomib.
Amiodarone Amiodarone The serum concentration of Bortezomib can be increased when it is combined with Amiodarone.
Buspirone Buspirone The metabolism of Buspirone can be decreased when combined with Bortezomib.
Lovastatin Lovastatin The metabolism of Bortezomib can be decreased when combined with Lovastatin.
Ciprofloxacin Ciprofloxacin The metabolism of Bortezomib can be decreased when combined with Ciprofloxacin.
Diclofenac Diclofenac The metabolism of Diclofenac can be decreased when combined with Bortezomib.
Fluoxetine Fluoxetine The serum concentration of Bortezomib can be increased when it is combined with Fluoxetine.
Nimodipine Nimodipine The risk or severity of QTc prolongation can be increased when Bortezomib is combined with Nimodipine.
Interferon Alfa-2b Injection Interferon Alfa-2b Injection The risk or severity of adverse effects can be increased when Interferon alfa-2b is combined with Bortezomib.
Clozapine Clozapine The risk or severity of neutropenia can be increased when Bortezomib is combined with Clozapine.
Idarubicin Idarubicin The risk or severity of adverse effects can be increased when Bortezomib is combined with Idarubicin.
Ofloxacin Ofloxacin The risk or severity of QTc prolongation can be increased when Bortezomib is combined with Ofloxacin.
Fludarabine Injection Fludarabine Injection The risk or severity of adverse effects can be increased when Bortezomib is combined with Fludarabine.
Pentostatin Injection Pentostatin Injection The risk or severity of adverse effects can be increased when Bortezomib is combined with Pentostatin.
Clarithromycin Clarithromycin The metabolism of Clarithromycin can be decreased when combined with Bortezomib.
Etodolac Etodolac The metabolism of Etodolac can be decreased when combined with Bortezomib.
Felodipine Felodipine The metabolism of Bortezomib can be decreased when combined with Felodipine.
Nabumetone Nabumetone The metabolism of Nabumetone can be decreased when combined with Bortezomib.
Pravastatin Pravastatin The serum concentration of Bortezomib can be increased when it is combined with Pravastatin.
Simvastatin Simvastatin The serum concentration of Bortezomib can be increased when it is combined with Simvastatin.
Epoetin Alfa, Injection Epoetin Alfa, Injection The risk or severity of Thrombosis can be increased when Erythropoietin is combined with Bortezomib.
Teniposide Injection Teniposide Injection The metabolism of Teniposide can be decreased when combined with Bortezomib.
Itraconazole Itraconazole The metabolism of Itraconazole can be decreased when combined with Bortezomib.
Atovaquone Atovaquone The metabolism of Bortezomib can be decreased when combined with Atovaquone.
Rifabutin Rifabutin The metabolism of Bortezomib can be increased when combined with Rifabutin.
Sotalol Sotalol The metabolism of Sotalol can be decreased when combined with Bortezomib.
Bisoprolol Bisoprolol The serum concentration of Bortezomib can be increased when it is combined with Bisoprolol.
Zolpidem Zolpidem The metabolism of Zolpidem can be decreased when combined with Bortezomib.
Doxazosin Doxazosin The metabolism of Doxazosin can be decreased when combined with Bortezomib.
Isradipine Isradipine The metabolism of Isradipine can be decreased when combined with Bortezomib.
Omeprazole Omeprazole The metabolism of Omeprazole can be increased when combined with Bortezomib.
Cisapride Cisapride The metabolism of Bortezomib can be decreased when combined with Cisapride.
Fluvastatin Fluvastatin The metabolism of Fluvastatin can be decreased when combined with Bortezomib.
Venlafaxine Venlafaxine The metabolism of Venlafaxine can be decreased when combined with Bortezomib.
Famciclovir Famciclovir The metabolism of Bortezomib can be decreased when combined with Famciclovir.
Fluvoxamine Fluvoxamine The metabolism of Bortezomib can be decreased when combined with Fluvoxamine.
Nefazodone Nefazodone The metabolism of Bortezomib can be decreased when combined with Nefazodone.
Lamotrigine Lamotrigine The risk or severity of QTc prolongation can be increased when Bortezomib is combined with Lamotrigine.
Losartan Losartan The metabolism of Losartan can be decreased when combined with Bortezomib.
Tramadol Tramadol The metabolism of Tramadol can be decreased when combined with Bortezomib.
Vinorelbine Injection Vinorelbine Injection The risk or severity of adverse effects can be increased when Bortezomib is combined with Vinorelbine.
Carboplatin Injection Carboplatin Injection The risk or severity of adverse effects can be increased when Bortezomib is combined with Carboplatin.
Moexipril Moexipril The risk or severity of QTc prolongation can be increased when Bortezomib is combined with Moexipril.
Lansoprazole Lansoprazole The metabolism of Lansoprazole can be increased when combined with Bortezomib.
Ifosfamide Injection Ifosfamide Injection The metabolism of Ifosfamide can be increased when combined with Bortezomib.
Pegaspargase Injection Pegaspargase Injection The risk or severity of adverse effects can be increased when Pegaspargase is combined with Bortezomib.
Nicardipine Nicardipine The metabolism of Bortezomib can be decreased when combined with Nicardipine.
Bupropion Bupropion The metabolism of Bortezomib can be decreased when combined with Bupropion.
Ticlopidine Ticlopidine The metabolism of Bortezomib can be decreased when combined with Ticlopidine.
Saquinavir Saquinavir The metabolism of Saquinavir can be decreased when combined with Bortezomib.
Dalteparin Injection Dalteparin Injection The risk or severity of bleeding can be increased when Dalteparin is combined with Bortezomib.
Riluzole Riluzole The metabolism of Riluzole can be decreased when combined with Bortezomib.
Glimepiride Glimepiride The metabolism of Glimepiride can be decreased when combined with Bortezomib.
Anastrozole Anastrozole The risk or severity of cardiotoxicity can be increased when Bortezomib is combined with Anastrozole.
Gemcitabine Injection Gemcitabine Injection The risk or severity of adverse effects can be increased when Bortezomib is combined with Gemcitabine.
Ritonavir Ritonavir The serum concentration of Bortezomib can be increased when it is combined with Ritonavir.
Docetaxel Injection Docetaxel Injection The metabolism of Docetaxel can be decreased when combined with Bortezomib.
Clomipramine Clomipramine The metabolism of Clomipramine can be decreased when combined with Bortezomib.
Zafirlukast Zafirlukast The metabolism of Bortezomib can be decreased when combined with Zafirlukast.
Mirtazapine Mirtazapine The metabolism of Mirtazapine can be decreased when combined with Bortezomib.
Topiramate Topiramate The metabolism of Bortezomib can be increased when combined with Topiramate.
Zileuton Zileuton The metabolism of Zileuton can be decreased when combined with Bortezomib.
Valsartan Valsartan The metabolism of Bortezomib can be decreased when combined with Valsartan.
Insulin Lispro Injection Insulin Lispro Injection The metabolism of Bortezomib can be increased when combined with Insulin lispro.
Donepezil Donepezil The metabolism of Donepezil can be decreased when combined with Bortezomib.
Nelfinavir Nelfinavir The metabolism of Nelfinavir can be decreased when combined with Bortezomib.
Fexofenadine Fexofenadine The serum concentration of Bortezomib can be increased when it is combined with Fexofenadine.
Azithromycin Azithromycin The metabolism of Azithromycin can be decreased when combined with Bortezomib.
Carvedilol Carvedilol The serum concentration of Carvedilol can be increased when it is combined with Bortezomib.
Nilutamide Nilutamide The metabolism of Bortezomib can be decreased when combined with Nilutamide.
Flutamide Flutamide The metabolism of Flutamide can be decreased when combined with Bortezomib.
Selegiline Selegiline The metabolism of Bortezomib can be decreased when combined with Selegiline.
Bicalutamide Bicalutamide The metabolism of Bortezomib can be decreased when combined with Bicalutamide.
Sertraline Sertraline The metabolism of Sertraline can be decreased when combined with Bortezomib.
Propafenone Propafenone The serum concentration of Bortezomib can be increased when it is combined with Propafenone.
Raloxifene Raloxifene The metabolism of Bortezomib can be decreased when combined with Raloxifene.
Irbesartan Irbesartan The metabolism of Irbesartan can be decreased when combined with Bortezomib.
Tamsulosin Tamsulosin The metabolism of Tamsulosin can be decreased when combined with Bortezomib.
Quetiapine Quetiapine The risk or severity of QTc prolongation can be increased when Bortezomib is combined with Quetiapine.
Cetirizine Cetirizine The risk or severity of QTc prolongation can be increased when Bortezomib is combined with Cetirizine.
Paroxetine Paroxetine The metabolism of Bortezomib can be decreased when combined with Paroxetine.
Tolcapone Tolcapone The metabolism of Bortezomib can be decreased when combined with Tolcapone.
Citalopram Citalopram The risk or severity of QTc prolongation can be increased when Bortezomib is combined with Citalopram.
Capecitabine Capecitabine The metabolism of Capecitabine can be decreased when combined with Bortezomib.
Efavirenz Efavirenz The metabolism of Bortezomib can be decreased when combined with Efavirenz.
Sildenafil Sildenafil The serum concentration of Bortezomib can be increased when it is combined with Sildenafil.
Trastuzumab Injection Trastuzumab Injection Trastuzumab may increase the neutropenic activities of Bortezomib.
Celecoxib Celecoxib The metabolism of Celecoxib can be decreased when combined with Bortezomib.
Rosiglitazone Rosiglitazone The metabolism of Bortezomib can be decreased when combined with Rosiglitazone.
Tolterodine Tolterodine The risk or severity of QTc prolongation can be increased when Bortezomib is combined with Tolterodine.
Thalidomide Thalidomide The risk or severity of adverse effects can be increased when Bortezomib is combined with Thalidomide.
Nateglinide Nateglinide The metabolism of Nateglinide can be decreased when combined with Bortezomib.
Galantamine Galantamine The risk or severity of QTc prolongation can be increased when Bortezomib is combined with Galantamine.
Rabeprazole Rabeprazole The metabolism of Rabeprazole can be decreased when combined with Bortezomib.
Terbinafine Terbinafine The metabolism of Bortezomib can be decreased when combined with Terbinafine.

Content provided by: AHFS® Patient Medication Information™. © Copyright, 2021. The American Society of Health-System Pharmacists